We are a biotechnology company that is dedicated to developing treatments for medical conditions that have the potential to change people’s lives. We see each clinical trial as a key milestone on this journey.
We aim to develop innovative therapies focused on the health outcomes that matter most to patients by understanding the challenges faced throughout their care pathways
Medical breakthroughs are discovered by those willing to look for them. We charter through unknown territory to develop treatments that have the potential to change lives
We are not constrained by the status quo. Our in-depth expertise means we can adapt and meet every challenge as a unique opportunity
We follow rigorous procedures and guidelines to ensure Galapagos is able to deliver to the highest standards and ethics for volunteers and patients
Through the discovery of proteins that play a role in medical conditions, we can develop specific treatments that address the course of the medical condition itself, rather than just the symptoms. Hear about how this novel approach is used in practice and applied to medical conditions such as rheumatoid arthritis.
GL-NA-NA-202105-00001, May 2021
Understanding the true physical and emotional burden of medical conditions fuels our ambition to bring life-changing treatments to the people who need them most. To achieve this we use our innovative three-step approach.
Using human primary cells and patient cells, we discover which proteins (‘targets’) play a key role in causing diseases such as rheumatoid arthritis, inflammatory bowel disease and fibrosis
We then develop small molecules that inhibit these targets, restore the balance and thereby positively influence the course of a disease
To deliver revolutionary treatments that can change people's lives
We have ongoing clinical studies, including those in inflammation and fibrosis, taking place in six continents across the world.
If you are an investigator and interested in working with Galapagos, please contact us.
